| Literature DB >> 16712861 |
Ryan M Krisko1, Kieran McLaughlin, Michael J Koenigbauer, Craig E Lunte.
Abstract
This paper describes a strategy for the development of chromatographic methods for drug candidates based upon the use of simple MS compatible mobile phases and optimization of the chromatographic selectivity through variations of the stationary phase and mobile phase pH. The strategy employs an automated column selection system and a series of HPLC columns, varying in hydrophobicity and silanol activity, in combination with DryLab software to develop chromatographic methods for the separation of mixtures of bupivacaine and its metabolites; acidic, basic, and neutral compounds; and atenolol, nitrendipine, and their degradation products.Mesh:
Substances:
Year: 2006 PMID: 16712861 PMCID: PMC2519830 DOI: 10.1016/j.chroma.2006.04.065
Source DB: PubMed Journal: J Chromatogr A ISSN: 0021-9673 Impact factor: 4.759